Efficient presentation of tumor idiotype to autologous T cells by CD83 + dendritic cells derived from highly purified circulating CD14 + monocytes in multiple myeloma patients

By Ratta M.   Curti A.   Fogli M.   Pantucci M.   Viscomi G.   Tazzari P.   Fagnoni F.   Vescovini R.   Sansoni P.   Tura S.   Lemoli R.M.  

Experimental Hematology, Vol. 28, Iss. 8, 2000-08 ,pp. : 931-940

Elsevier

Access to resources Recommend Favorite

Vaccination with dendritic cell–tumor fusion cells in multiple myeloma patients: a promising strategy?

By Garcia-Marquez Maria A   Shimabukuro-Vornhagen Alexander   Theurich Sebastian   von Bergwelt-Baildon Michael  

Immunotherapy, Vol. 5, Iss. 10, 2013-10 ,pp. : 1039-1042

Future Medicine

Access to resources Recommend Favorite

Th1/Th2 Cells in Patients with Multiple Myeloma

By Murakami Hirokazu   Ogawara Hatsue   Hiroshi Handa  

Hematology, Vol. 9, Iss. 1, 2004-02 ,pp. : 41-45

Maney Publishing

Access to resources Recommend Favorite

Relation between S-phase fraction of myeloma cells and anemia in patients with multiple myeloma - a randomized multicenter study. The European study group of erythropoietin (Epoetin Beta) treatment in multiple myeloma and non-Hodgkin's lymphoma

By Fossa A.   Brandhorst D.   Myklebust J.H.   Seeber S.   Nowrousian M.R.  

Experimental Hematology, Vol. 27, Iss. 11, 1999-11 ,pp. : 1621-1626

Elsevier

Access to resources Recommend Favorite

Meningeal and cerebral involvement in multiple myeloma patients

By Patriarca F.   Zaja F.   Silvestri F.   Sperotto A.   Scalise A.   Gigli G.   Fanin R.  

Annals of Hematology, Vol. 80, Iss. 12, 2001-12 ,pp. : 758-762

Springer Publishing Company

Access to resources Recommend Favorite